Cervical Cancer Trial, Recruiting NCT05390567 Sponsor: University of Florida Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT05390567
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 25 to 65, based on American Cancer Society screening recommendations
  • People who were assigned female sex at birth
  • People who have not previously had cervical cancer
  • People who have not previously had a hysterectomy (surgical removal of the uterus)
  • People who are not currently pregnant (based on self-report)
  • People who are not currently having their menstrual period at the time of the visit
  • People who have not used any vaginal products — such as oil-based lubricants, antifungal treatments, or douches — in the 2 days before the visit (vaginal contraceptives, condoms, and water-based lubricants are allowed)
  • People who have not given birth in the past 12 weeks
  • People who self-report not having had cervical cancer screening in the past 4 or more years, or who report being overdue according to their doctor's recommended screening schedule
  • People who have used the Mobile Outreach Clinic (MOC) in the past, have no regular doctor or healthcare provider, or whose regular provider does not offer cervical cancer screening
  • People who live in areas served by the Mobile Outreach Clinic's travel routes
  • People who have access to a mobile phone that can receive messages, or who have a valid email address

Who may not be able to join:

  • People who have previously had cervical cancer
  • People who have previously had a hysterectomy
  • People who are currently pregnant
  • People who are currently menstruating at the time of the visit (confirm with trial site — the study team may be able to re-contact these individuals later)
  • People who have used certain vaginal products in the 2 days before the visit (confirm with trial site — the study team may be able to re-contact these individuals later)
  • People who have given birth within the past 12 weeks (confirm with trial site — the study team may be able to re-contact these individuals later)
  • People who live outside the areas where the Mobile Outreach Clinic travels
  • People who do not have access to a mobile phone or a valid email address

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ramzi A Salloum, PhD, Division Director, Department of Health Outcomes and Biomedical Informatics, University of Florida; Associate Director, Office of Community Outreach and Engagement, UFHealth Cancer Center

Phone: 352-3253703

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 June 2024
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence to steps in the cervical cancer screening continuum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov